Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Singleton, WG"'
Autor:
Singleton WG, Collins AM, Bienemann AS, Killick-Cole CL, Haynes HR, Asby DJ, Butts CP, Wyatt MJ, Barua NU, Gill SS
Publikováno v:
International Journal of Nanomedicine, Vol Volume 12, Pp 1385-1399 (2017)
WG Singleton,1,2 AM Collins,3 AS Bienemann,1 CL Killick-Cole,1 HR Haynes,4 DJ Asby,1 CP Butts,5 MJ Wyatt,1 NU Barua,1,2 SS Gill1,2 1Functional Neurosurgery Research Group, School of Clinical Sciences, University of Bristol, 2Department of Neurosurger
Externí odkaz:
https://doaj.org/article/aab501023622452a81f2d895f5be6579
Autor:
Haynes, HR, Scott, HL, Killick-Cole, CL, Shaw, G, Brend, T, Hares, KM, Redondo, J, Kemp, KC, Ballesteros, LS, Herman, A, Cordero-Llana, O, Singleton, WG, Mills, F, Batstonew, T, Bulstrode, H, Kauppinen, RA, Wurdak, H, Uney, JB, Short, SC, Wilkins, A, Kurian, KM
The overall survival for patients with primary glioblastoma is very poor. Glioblastoma contains a subpopulation of glioma stem cells (GSC) that are responsible for tumour initiation, treatment resistance and recurrence. PPARα is a transcription fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::5d69f4e9d810bdc51bc1a822e38b3174
Autor:
Haynes HR; Brain Tumour Research Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Department of Cellular Pathology, North Bristol NHS Trust, Bristol, UK., Scott HL; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Killick-Cole CL; Functional Neurosurgery Research Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Shaw G; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Brend T; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Hares KM; Multiple Sclerosis and Stem Cell Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Redondo J; Multiple Sclerosis and Stem Cell Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Kemp KC; Multiple Sclerosis and Stem Cell Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Ballesteros LS; Flow Cytometry Facility, School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Herman A; Flow Cytometry Facility, School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Cordero-Llana O; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Singleton WG; Functional Neurosurgery Research Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Department of Neurosurgery, North Bristol NHS Trust, Bristol, UK., Mills F; Department of Clinical Biochemistry, North Bristol NHS Trust, Bristol, UK., Batstone T; Bioinformatics Facility, School of Biological Sciences, University of Bristol, Bristol, UK., Bulstrode H; Department of Clinical Neuroscience and Stem Cell Institute, University of Cambridge, Cambridge, UK., Kauppinen RA; Clinical Research and Imaging Centre, University of Bristol, Bristol, UK., Wurdak H; Stem Cells and Brain Tumour Group, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Uney JB; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Short SC; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Wilkins A; Multiple Sclerosis and Stem Cell Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Kurian KM; Brain Tumour Research Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Publikováno v:
The Journal of pathology [J Pathol] 2019 Apr; Vol. 247 (4), pp. 422-434. Date of Electronic Publication: 2018 Dec 27.
Autor:
Asby DJ; Functional Neurosurgery Research Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK, steven.gill@nbt.nhs.uk., Killick-Cole CL; Functional Neurosurgery Research Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK, steven.gill@nbt.nhs.uk., Boulter LJ; Functional Neurosurgery Research Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK, steven.gill@nbt.nhs.uk., Singleton WG; Functional Neurosurgery Research Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK, steven.gill@nbt.nhs.uk.; Department of Neurosurgery, North Bristol NHS Trust, Southmead Hospital, Bristol, UK, steven.gill@nbt.nhs.uk., Asby CA; Department of Neurology, North Bristol NHS Trust, Southmead Hospital, Bristol, UK., Wyatt MJ; Functional Neurosurgery Research Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK, steven.gill@nbt.nhs.uk., Barua NU; Functional Neurosurgery Research Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK, steven.gill@nbt.nhs.uk.; Department of Neurosurgery, North Bristol NHS Trust, Southmead Hospital, Bristol, UK, steven.gill@nbt.nhs.uk., Bienemann AS; Functional Neurosurgery Research Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK, steven.gill@nbt.nhs.uk., Gill SS; Functional Neurosurgery Research Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK, steven.gill@nbt.nhs.uk.; Department of Neurosurgery, North Bristol NHS Trust, Southmead Hospital, Bristol, UK, steven.gill@nbt.nhs.uk.
Publikováno v:
Cancer management and research [Cancer Manag Res] 2018 Sep 12; Vol. 10, pp. 3483-3500. Date of Electronic Publication: 2018 Sep 12 (Print Publication: 2018).
Autor:
Williams MJ; Brain Tumour Research Group, Institute of Clinical Neurosciences, University of Bristol , Bristol , UK., Singleton WG; Functional Neurosurgery Research Group, Institute of Clinical Neurosciences, University of Bristol , Bristol , UK., Lowis SP; Department of Paediatric and Adolescent Oncology, Bristol Royal Hospital for Children , Bristol , UK., Malik K; Cancer Epigenetics Laboratory, Cellular and Molecular Medicine, University of Bristol , Bristol , UK., Kurian KM; Brain Tumour Research Group, Institute of Clinical Neurosciences, University of Bristol , Bristol , UK.
Publikováno v:
Frontiers in oncology [Front Oncol] 2017 Mar 28; Vol. 7, pp. 45. Date of Electronic Publication: 2017 Mar 28 (Print Publication: 2017).
Autor:
Singleton WG; Department of Neurosurgery, Frenchay Hospital, Frenchay Park Road, Bristol, UK. williamsingleton@doctors.org.uk, Ramnarine D, Patel N, Wigfield C
Publikováno v:
British journal of neurosurgery [Br J Neurosurg] 2012 Jun; Vol. 26 (3), pp. 429-31. Date of Electronic Publication: 2011 Nov 15.
Autor:
Singleton WG; Department of Paediatric Neurosurgery, Frenchay Hospital, Bristol, UK., Bacon A, Edwards RJ
Publikováno v:
Pediatric neurosurgery [Pediatr Neurosurg] 2012; Vol. 48 (4), pp. 258-60. Date of Electronic Publication: 2013 Apr 06.
Autor:
Singleton WG; Department of Neurological Surgery, John Radcliffe Hospital, Oxford, UK. williamsingleton@doctors.org.uk, Lawrence T, Green AL, Jeans A, Kerr RS
Publikováno v:
Acta neurochirurgica [Acta Neurochir (Wien)] 2010 May; Vol. 152 (5), pp. 881-3. Date of Electronic Publication: 2009 Oct 06.
Autor:
Briggs JH; Department of Respiratory Medicine, Heatherwood and Wexham Park Hospitals NHS Foundation Trust, King Edward VII Hospital,Windsor, Berkshire, SL4 3DP, UK. jhbriggs@mac.com, Singleton WG, Burke MM, Hart LA, Parker RJ
Publikováno v:
Cases journal [Cases J] 2009 Jul 21; Vol. 2, pp. 6963. Date of Electronic Publication: 2009 Jul 21.